SCHEMBL30544073

SCHEMBL30544073

CS(=O)(=O)Nc1cccc(NC(=O)c2cc(C(=O)Nc3cccc(-c4cccnc4)c3)cs2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.53
▸ HTT P42858 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ DHX9 Q08211 1/20 0.49
▸ PIP4K2A P48426 2/20 0.48
▸ PIP4K2B P78356 2/20 0.48
▸ FYN P06241 1/20 0.48
▸ PIKFYVE Q9Y2I7 1/20 0.47
▸ DYRK1A Q13627 3/20 0.46
▸ KCNK3 O14649 1/20 0.46
▸ IRAK4 Q9NWZ3 1/20 0.46
▸ ABL1 P00519 2/20 0.45
▸ PDGFRB P09619 2/20 0.45
▸ SRC P12931 2/20 0.45
▸ PDGFRA P16234 2/20 0.45
▸ BRAF P15056 1/20 0.44
▸ CNR1 P21554 1/20 0.44
▸ USP7 Q93009 1/20 0.44
▸ USP47 Q96K76 1/20 0.44
▸ BCR P11274 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25366609 1.00 NAMPT (0.53) NAMPTHTTLMNADHX9PIP4K2A
SCHEMBL25368168 0.90 NAMPT (0.51) NAMPTHTTLMNADHX9PIP4K2A
SCHEMBL30544037 0.85 DHX9 (0.52) NAMPTHTTLMNADHX9PIP4K2A
SCHEMBL25369304 0.85 DHX9 (0.52) NAMPTHTTLMNADHX9PIP4K2A
SCHEMBL30543946 0.83 DHX9 (0.53) HTTLMNADHX9KCNK3L3MBTL1
SCHEMBL25368280 0.83 DHX9 (0.53) HTTLMNADHX9KCNK3L3MBTL1
SCHEMBL30543890 0.82 ALDH1A1 (0.50) NAMPTHTTLMNADHX9L3MBTL1
SCHEMBL25368167 0.82 ALDH1A1 (0.50) NAMPTHTTLMNADHX9L3MBTL1
SCHEMBL25368947 0.82 HTT (0.69) HTTLMNA
SCHEMBL30543863 0.82 HTT (0.69) HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479380-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 — — EP disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO disclosed
Send feedback